Morgan Stanley
NTUS

Morgan Stanley’s Natus Medical Inc NTUS Stock Holding History

Morgan Stanley’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-856,406
Closed -$28.1M – 8204
2022
Q2 		$28.1M Buy
856,406
+720,237
+529% +$22.8M ﹤0.01% 1921
2022
Q1 		$3.58M Sell
136,169
-2,425
-2% -$59.2K ﹤0.01% 4038
2021
Q4 		$3.29M Sell
138,594
-29,480
-18% -$728K ﹤0.01% 4165
2021
Q3 		$4.21M Sell
168,074
-32,886
-16% -$838K ﹤0.01% 3917
2021
Q2 		$5.22M Sell
200,960
-102,459
-34% -$2.79M ﹤0.01% 3736
2021
Q1 		$7.77M Buy
303,419
+159,423
+111% +$4.09M ﹤0.01% 2921
2020
Q4 		$2.88M Buy
143,996
+56,907
+65% +$1.11M ﹤0.01% 3826
2020
Q3 		$1.49M Sell
87,089
-12,082
-12% -$228K ﹤0.01% 3912
2020
Q2 		$2.16M Buy
99,171
+3,132
+3% +$71.7K ﹤0.01% 3518
2020
Q1 		$2.22M Sell
96,039
-71,756
-43% -$2.09M ﹤0.01% 3273
2019
Q4 		$5.54M Buy
167,795
+45,614
+37% +$1.46M ﹤0.01% 3095
2019
Q3 		$3.89M Sell
122,181
-174,670
-59% -$5.09M ﹤0.01% 3138
2019
Q2 		$7.63M Buy
296,851
+98,067
+49% +$2.5M ﹤0.01% 2453
2019
Q1 		$5.05M Buy
198,784
+82,349
+71% +$2.46M ﹤0.01% 2702
2018
Q4 		$3.96M Sell
116,435
-84,285
-42% -$2.74M ﹤0.01% 3159
2018
Q3 		$7.16M Buy
200,720
+126,079
+169% +$4.45M ﹤0.01% 2779
2018
Q2 		$2.58M Sell
74,641
-3,214
-4% -$113K ﹤0.01% 3842
2018
Q1 		$2.62M Sell
77,855
-21,355
-22% -$676K ﹤0.01% 3713
2017
Q4 		$3.79M Buy
99,210
+46,632
+89% +$1.86M ﹤0.01% 3397
2017
Q3 		$1.97M Sell
52,578
-95,683
-65% -$3.38M ﹤0.01% 3902
2017
Q2 		$5.53M Buy
148,261
+65,227
+79% +$2.36M ﹤0.01% 2735
2017
Q1 		$3.26M Sell
83,034
-269,798
-76% -$10.1M ﹤0.01% 3352
2016
Q4 		$12.3M Buy
352,832
+329,702
+1,425% +$12.9M ﹤0.01% 2031
2016
Q3 		$909K Sell
23,130
-46,280
-67% -$1.85M ﹤0.01% 4111
2016
Q2 		$2.63M Sell
69,410
-7,591
-10% -$254K ﹤0.01% 3196
2016
Q1 		$2.96M Sell
77,001
-165,582
-68% -$6.17M ﹤0.01% 3003
2015
Q4 		$11.7M Buy
242,583
+125,964
+108% +$5.83M ﹤0.01% 1836
2015
Q3 		$4.6M Buy
116,619
+77,493
+198% +$3.29M ﹤0.01% 2727
2015
Q2 		$1.67M Sell
39,126
-16,616
-30% -$662K ﹤0.01% 3784
2015
Q1 		$2.2M Buy
55,742
+1,796
+3% +$66.2K ﹤0.01% 3518
2014
Q4 		$1.94M Sell
53,946
-5,133
-9% -$172K ﹤0.01% 3588
2014
Q3 		$1.74M Sell
59,079
-12,960
-18% -$358K ﹤0.01% 3559
2014
Q2 		$1.81M Sell
72,039
-61,179
-46% -$1.51M ﹤0.01% 3560
2014
Q1 		$3.44M Sell
133,218
-52,141
-28% -$1.31M ﹤0.01% 2944
2013
Q4 		$4.17M Buy
185,359
+45,130
+32% +$872K ﹤0.01% 2737
2013
Q3 		$1.99M Sell
140,229
-75,574
-35% -$1.01M ﹤0.01% 3220
2013
Q2 		$2.95M Buy
+215,803
New +$2.94M ﹤0.01% 2822

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Morgan Stanley's NTUS Position: Q3 2022 in Review

Morgan Stanley sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 856,406 shares — an estimated $28.1M sold.

Morgan Stanley first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $28.1M in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Morgan Stanley reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Morgan Stanley sold 856,406 Natus Medical Inc shares in Q3 2022, an estimated $28.1M.
  • Morgan Stanley first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
  • Morgan Stanley's Natus Medical Inc position peaked at $28.1M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.